Potential biomarkers for the prognosis of gastrointestinal stromal tumors

This editorial comments on a study exploring preoperative inflammation markers and gastrointestinal stromal tumor (GIST) recurrence after surgery. While traditional prognostic factors are known, the study offers a new model using MLR and PLR to assess postoperative recurrence risk. The article also discusses other inflammatory markers and novel parameters like PENK and SLITRK3, emphasizing the potential of integrating these markers for personalized GIST management.